Schizophrenia
Conditions
Brief summary
The purpose of this study is to determine whether individual and/ or system orientated interventions can help the problem of people with schizophrenia dropping out of their drug treatment
Detailed description
50% of people with schizophrenia do not take the prescribed medication leading to repeating relapses with loss of social and cognitive skills. The individual intervention is based on Motivational Interviewing by Miller and Concordance Strategies by R. Gray.It is a cognitive behavioral therapy. The system orientated intervention is building on principles from quality assurance and clinical risk managing. It seeks to improve the quality in the medical treatment by use of standards, monitoring, audit and root cause analysis,and thereby trying to find weak points in the system and subsequently improve the common practice.
Interventions
BEHAVIORALmotivational interviewing
An individual intervention building on the Motivational Interviewing by Miller and Rollnick. Several studies has proved effectiveness of this therapy form in improving drug compliance. Patients will be offered individual motivational therapy
OTHERThe System-Orientated Intervention
Principles in this intervention come from Clinical Risk Managing and quality assurance. It focuses on daily problems in drug handling, including dropping out of drug therapy, by looking at the system as a whole.Some cases, where patients dropped out of drug therapy will be carefully analysed in order to identify week points in the system, and subsequently alter the instructions for drug therapy, information, reminders and so on.
Sponsors
Ministry of the Interior and Health, Denmark
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
23 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnoses of schizophrenia or schizoaffective psychosis * 23 years or more * Ethnic dane * Living in the city of Odense.
Exclusion criteria
* not subject to legal action
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| compliance assessed on a compliance-scale | follow-up time 6 months |
Secondary
| Measure | Time frame |
|---|---|
| assessment on a variety of scales concerning subjective well-being, GAF, PANSS-remission,CGI, side-effects. | 6 months |
Countries
Denmark
Outcome results
None listed